5701 - 5725 of 6258 Results
Title
Year
-
OPENTitle: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6924570Citation Count: 1
-
OPENTitle: Provisional case definitions for COVID-19-associated neurological diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 890End Page: 891Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30373-2Best OA location URL: http://www.thelancet.com/article/S1474442220303732/pdfCitation Count: 7
-
OPENTitle: Huntington's disease in BangladeshJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 644End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30216-7Best OA location URL: http://www.thelancet.com/article/S1474442220302167/pdfCitation Count: 1
-
OPENTitle: Initiating pharmacotherapy in early Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30225-8Best OA location URL: https://pure.amc.nl/en/publications/initiating-pharmacotherapy-in-early-parkinsons-disease(38fe3866-cce3-4a08-934a-d979a3cec1cc).htmlCitation Count: 5
-
OPENTitle: Long before Huntington's disease: what matters most?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 473End Page: 475Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30156-3Best OA location URL: http://www.thelancet.com/article/S1474442220301563/pdfCitation Count: 0
-
OPENTitle: The Nrf2-mediated defense mechanism associated with HFE genotype limits vulnerability to oxidative stress-induced toxicityJournal Name: ToxicologyPublisher: Elsevier BVVol: 441Issue #:Start Page: 152525End Page: 152525Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.tox.2020.152525Best OA location URL: https://scholarsphere.psu.edu/resources/0165b409-31f0-464c-9424-715ab3ca7de4Citation Count: 13
-
OPENTitle: Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeysJournal Name: eBioMedicinePublisher: Elsevier BVVol: 59Issue #:Start Page: 102944End Page: 102944Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2020.102944Best OA location URL: http://www.thelancet.com/article/S2352396420303200/pdfCitation Count: 63
- Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson Disease2020OPENTitle: Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson DiseaseJournal Name: World NeurosurgeryPublisher: Elsevier BVVol: 139Issue #:Start Page: e784End Page: e791Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.wneu.2020.04.160Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S187887502030869XCitation Count: 2
-
OPENTitle: Not only loud but also intelligibleJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 24Issue #:Start Page: 100456End Page: 100456Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2020.100456Best OA location URL: http://www.thelancet.com/article/S2589537020302005/pdfCitation Count: 2
-
OPENTitle: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell deathJournal Name: Redox BiologyPublisher: Elsevier BVVol: 28Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2019.101377Best OA location URL: https://doi.org/10.1016/j.redox.2019.101377Citation Count: 27
-
OPENTitle: Transdifferentiation of Mouse Embryonic Fibroblasts into Dopaminergic Neurons Reactivates LINE-1 Repetitive ElementsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 60End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.002Best OA location URL: http://www.cell.com/article/S2213671119304163/pdfCitation Count: 22
-
OPENTitle: A Survey of Rare Epigenetic Variation in 23,116 Human Genomes Identifies Disease-Relevant Epivariations and CGG ExpansionsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 107Issue #: 4Start Page: 654End Page: 669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2020.08.019Best OA location URL: http://www.cell.com/article/S0002929720302883/pdfCitation Count: 53
-
OPENTitle: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 1Start Page: 35End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7671949Citation Count: 5
-
OPENTitle: Developing therapies for Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 10Start Page: 797End Page: 797Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3Best OA location URL: http://www.thelancet.com/article/S1474442220303203/pdfCitation Count: 4
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1
-
OPENTitle: Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and “OFF” episodesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 110End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.08.028Best OA location URL: http://www.prd-journal.com/article/S1353802020306945/pdfCitation Count: 15
-
OPENTitle: Analysis of heterozygous PRKN variants and copy number variations in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e28End Page: e28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.123Best OA location URL: https://doi.org/10.1101/2020.05.07.20072728Citation Count: 6
-
OPENTitle: Evaluation of an Interdisciplinary Screening Program for People With Parkinson Disease and Movement DisordersJournal Name: Archives of Rehabilitation Research and Clinical TranslationPublisher: Elsevier BVVol: 2Issue #: 3Start Page: 100067End Page: 100067Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.arrct.2020.100067Best OA location URL: https://doi.org/10.1016/j.arrct.2020.100067Citation Count: 3
-
OPENTitle: The Access Technology Program of the Indiana Clinical Translational Sciences Institute (CTSI): A model to facilitate access to cutting-edge technologies across a stateJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.525Citation Count: 0
-
OPENTitle: 4203 Re-engineering the Approach to Extremely Preterm Breech Deliveries with Student Led Team ScienceJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 118End Page: 118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.358Citation Count: 0
-
OPENTitle: 4169 The influence of serious mental illness on medical care of patients with lower back pain in the emergency departmentJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.360Citation Count: 0
-
OPENTitle: 4556 Gender homophily in translational collaborations; a network analysis study of investigators at one academic medical centerJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 118End Page: 118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.357Citation Count: 0
-
OPENTitle: 4265 Effect of individual characteristics, healthcare access, and built environment on care coordination outcomes related to cardiovascular disease risk factorsJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 117End Page: 118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.356Citation Count: 0
-
OPENTitle: Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 34Issue #: 1Start Page: 24End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000577Best OA location URL: https://doi.org/10.1037/neu0000577Citation Count: 20
-
OPENTitle: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 8Start Page: e038911End Page: e038911Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-038911Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/8/e038911.full.pdfCitation Count: 28